EPCAM and rectal cancer: The current study is a continuation of this research to further evaluate which of the rectal cancer-associated membrane proteins CEA, EpCAM, αvβ6, and uPAR is the most useful indicator of absence of residual vital cancer cells after neoadjuvant therapy.